Activin receptor-like kinase 1 (ALK1) receptor antagonist

Ask the supplier | View on supplier's website

Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma).

Supplier	Creative Biomart
Product #	HSP-339
Pricing	1 vial : USD $998

Feedback